NEOD Stock Overview
NeoDynamics AB (publ), a medical technology company, engages in the development of biopsy system to enhance diagnostics and treatment of breast cancer patients.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
NeoDynamics AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr0.95 |
52 Week High | kr62.70 |
52 Week Low | kr0.85 |
Beta | 1.24 |
1 Month Change | 0% |
3 Month Change | -43.45% |
1 Year Change | -98.31% |
3 Year Change | -99.67% |
5 Year Change | -99.77% |
Change since IPO | -99.81% |
Recent News & Updates
Shareholder Returns
NEOD | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | 1.1% | 1.0% | 1.1% |
1Y | -98.3% | -8.9% | 8.6% |
Return vs Industry: NEOD underperformed the Swedish Medical Equipment industry which returned -8.9% over the past year.
Return vs Market: NEOD underperformed the Swedish Market which returned 8.6% over the past year.
Price Volatility
NEOD volatility | |
---|---|
NEOD Average Weekly Movement | 8.5% |
Medical Equipment Industry Average Movement | 8.1% |
Market Average Movement | 6.2% |
10% most volatile stocks in SE Market | 13.5% |
10% least volatile stocks in SE Market | 3.6% |
Stable Share Price: NEOD's share price has been volatile over the past 3 months.
Volatility Over Time: NEOD's weekly volatility has decreased from 18% to 8% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | 9 | Matilda Salen | www.neodynamics.com |
NeoDynamics AB (publ), a medical technology company, engages in the development of biopsy system to enhance diagnostics and treatment of breast cancer patients. It develops NeoNavia, a precision biopsy system that offers clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment. The company was incorporated in 2015 and is based in Lidingö, Sweden.
NeoDynamics AB (publ) Fundamentals Summary
NEOD fundamental statistics | |
---|---|
Market cap | kr30.98m |
Earnings (TTM) | -kr92.66m |
Revenue (TTM) | kr751.00k |
41.3x
P/S Ratio-0.3x
P/E RatioIs NEOD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NEOD income statement (TTM) | |
---|---|
Revenue | kr751.00k |
Cost of Revenue | kr1.42m |
Gross Profit | -kr668.00k |
Other Expenses | kr92.00m |
Earnings | -kr92.66m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 01, 2024
Earnings per share (EPS) | -2.84 |
Gross Margin | -88.95% |
Net Profit Margin | -12,338.88% |
Debt/Equity Ratio | 0% |
How did NEOD perform over the long term?
See historical performance and comparison